Patent · US Expired

Inhibitors of integrin αvβ6

US7138417B2 · kind B2 · utility

3Cited by

12References

20Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Wolfgang Staehle · Ingelheim am Rhein, DE
Oliver Schadt · Rodenbach, DE
Alfred Jonczyk · Darmstadt, DE
Simon Goodman

Key dates

Filing date	Jan 15, 2003
Grant date	Nov 21, 2006
Priority date	—
Expiry date	May 20, 2023

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Novel biphenyl derivatives of the general formula I in which R1, R1′, R1″, R2, R2′, R3 and n are as defined in Patent claim 1, stereoisomers thereof and physiologically acceptable salts or solvates thereof are novel integrin inhibitors which preferentially inhibit the αvβ6 integrin receptor. The novel compounds can be used, in particular, as medicaments

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.